863 related articles for article (PubMed ID: 28878044)
1. Progress and prospects of early detection in lung cancer.
Blandin Knight S; Crosbie PA; Balata H; Chudziak J; Hussell T; Dive C
Open Biol; 2017 Sep; 7(9):. PubMed ID: 28878044
[TBL] [Abstract][Full Text] [Related]
2. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T
J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114
[TBL] [Abstract][Full Text] [Related]
3. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
[TBL] [Abstract][Full Text] [Related]
4. Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.
Loong HH; Raymond VM; Shiotsu Y; Chua DTT; Teo PML; Yung T; Skrzypczak S; Lanman RB; Mok TSK
Clin Lung Cancer; 2018 Sep; 19(5):e601-e608. PubMed ID: 29807856
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of the surgical treatment of patients with non-small cell lung cancer (NSCLC)--relation to DNA ploidy.
Gawrychowski J; Lackowska B; Gabriel A
Eur J Cardiothorac Surg; 2003 Jun; 23(6):870-7; discussion 877. PubMed ID: 12829060
[TBL] [Abstract][Full Text] [Related]
6. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
[TBL] [Abstract][Full Text] [Related]
7. Surgical outcomes in patients with small cell lung cancer: comparative analysis of computed tomograpy-detected patients with others.
Koizumi T; Fukushima T; Hamanaka K; Shiina T; Yoshida K; Kondo R; Yamamoto R; Nishizawa N
World J Surg Oncol; 2013 Mar; 11():61. PubMed ID: 23497006
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic characteristics and EGFR mutations in lung cancer patients aged below 45 years.
Xia J; Li H; Ji Y; Mi C; Chen G; Li P; Zhang R; Chen W; Wang J
Curr Probl Cancer; 2019 Aug; 43(4):363-370. PubMed ID: 30522775
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Different Surgical Approaches on the Perioperative Level of Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer.
Huang HB; Ge MJ
Thorac Cardiovasc Surg; 2016 Sep; 64(6):515-9. PubMed ID: 26030121
[TBL] [Abstract][Full Text] [Related]
11. CUG-binding protein 1 (CUGBP1) expression and prognosis of non-small cell lung cancer.
Jiao W; Zhao J; Wang M; Wang Y; Luo Y; Zhao Y; Tang D; Shen Y
Clin Transl Oncol; 2013 Oct; 15(10):789-95. PubMed ID: 23359188
[TBL] [Abstract][Full Text] [Related]
12. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
[TBL] [Abstract][Full Text] [Related]
13. Survival of M1a Non-Small Cell Lung Cancer Treated Surgically: A Retrospective Single-Center Study.
Liu T; Liu H; Wang G; Zhang C; Liu B
Thorac Cardiovasc Surg; 2015 Oct; 63(7):577-82. PubMed ID: 25893920
[TBL] [Abstract][Full Text] [Related]
14. Bronchoscopy-Guided Cooled Radiofrequency Ablation as a Novel Intervention Therapy for Peripheral Lung Cancer.
Koizumi T; Tsushima K; Tanabe T; Agatsuma T; Yokoyama T; Ito M; Kanda S; Kobayashi T; Yasuo M
Respiration; 2015; 90(1):47-55. PubMed ID: 26044954
[TBL] [Abstract][Full Text] [Related]
15. Single tube liquid biopsy for advanced non-small cell lung cancer.
de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
[TBL] [Abstract][Full Text] [Related]
16. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
17. Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
Zalewska-Ziob M; Dobija-Kubica K; Biernacki K; Adamek B; Kasperczyk J; Bruliński K; Ostrowska Z
Acta Biochim Pol; 2017; 64(4):641-646. PubMed ID: 29141053
[TBL] [Abstract][Full Text] [Related]
18. Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival.
Mayne NR; Mallipeddi MK; Darling AJ; Jeffrey Yang CF; Eltaraboulsi WR; Shoffner AR; Naqvi IA; D'Amico TA; Berry MF
Clin Lung Cancer; 2020 Sep; 21(5):407-414. PubMed ID: 32376115
[TBL] [Abstract][Full Text] [Related]
19. Analysis of MAT3 gene expression in NSCLC.
Zheng S; Du Y; Chu H; Chen X; Li P; Wang Y; Ma Y; Wang H; Zang W; Zhang G; Zhao G
Diagn Pathol; 2013 Oct; 8():166. PubMed ID: 24107548
[TBL] [Abstract][Full Text] [Related]
20. Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer.
Yoshida Y; Murayama T; Sato Y; Suzuki Y; Saito H; Nomura Y
Thorac Cardiovasc Surg; 2016 Sep; 64(6):507-14. PubMed ID: 26366891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]